Elevated circulating levels of IL-6 in schizophrenia

Schizophr Res. 1996 Jul 5;20(3):269-73. doi: 10.1016/0920-9964(96)00014-x.

Abstract

Schizophrenia may result from immune or inflammatory disorders, which are mediated by cytokines. Data in this field are heterogeneous and often contradictory. We investigated circulating levels of IL-6 and TNF-alpha, two distinct proinflammatory cytokines. Using immunoassay, we assessed IL-6 and TNF-alpha in serum from chronic schizophrenic patients (n = 30) and normal controls (n = 15). Circulating levels of IL-6 were higher in patients than in controls; those of TNF-alpha were not significantly higher than in controls. In addition, IL-6 levels were higher in patients with acute exacerbation of schizophrenia than in patients with remissions. Our results suggest that immunologic abnormalities in schizophrenia may be related to a specific inflammatory process mediated by IL-6. An interesting line of research would be the evaluation of IL-6 cerebral production in CSF.

MeSH terms

  • Adult
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / psychology
  • Chronic Disease
  • Female
  • Humans
  • Interleukin-6 / blood*
  • Male
  • Neurocognitive Disorders / diagnosis
  • Neurocognitive Disorders / immunology*
  • Neurocognitive Disorders / psychology
  • Reference Values
  • Schizophrenia / diagnosis
  • Schizophrenia / immunology*
  • Schizophrenic Psychology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha